AllianceBernstein
IMNM icon

AllianceBernstein’s Immunome IMNM Stock Holding History

AllianceBernstein’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.51M Buy
163,450
+70,460
+76% +$1.57M ﹤0.01% 1708
2025
Q4 		$2M Buy
92,990
+37,730
+68% +$662K ﹤0.01% 2004
2025
Q3 		$647K Hold
55,260
– – ﹤0.01% 2546
2025
Q2 		$514K Buy
55,260
+6,750
+14% +$55.3K ﹤0.01% 2628
2025
Q1 		$326K Sell
48,510
-5,280
-10% -$50.7K ﹤0.01% 2733
2024
Q4 		$571K Hold
53,790
– – ﹤0.01% 2577
2024
Q3 		$786K Hold
53,790
– – ﹤0.01% 2431
2024
Q2 		$651K Buy
+53,790
New +$841K ﹤0.01% 2519

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

AllianceBernstein's IMNM Position: Q1 2026 in Review

AllianceBernstein increased its Immunome (IMNM) stake by 76% in Q1 2026, buying an estimated $1.57M and bringing the position to 163,450 shares worth $3.51M. The position accounts for ﹤0.01% of the portfolio, ranked #1708.

AllianceBernstein first reported a position in IMNM in Q2 2024 and has held it in 8 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • AllianceBernstein held 163,450 shares of Immunome worth $3.51M as of Q1 2026.
  • AllianceBernstein bought 70,460 Immunome shares in Q1 2026, an estimated $1.57M.
  • Immunome made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #1708 holding.
  • AllianceBernstein first reported a position in Immunome in Q2 2024 and has held it in 8 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.